Clinical Trial Update: Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a vaccine therapy in unresectable metastatic melanoma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED